![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, February 07, 2015 7:42:13 PM
I'd still prefer to make it in person though, because Peregrine KOL's David Carbone (2015 President of IASLC) and Scott Antonia have spent their entire professional careers searching for the best treatments for lung cancer and both are backing Bavituximab, PS Targeting and must be for a very good reason.
Below are the details from the website and notice the red highlight => now available on webcast
Lots happening in March and not sure if anything happens but we have earnings and who knows, if anything of material happens before March 7th 2015... it only gives reason why this event now is being webcast.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110599254
------------------------------------------
Tampa HOPE Summit
A survivorship conference for anyone who has ever been
diagnosed with lung cancer
Saturday, March 7, 2015
While lung cancer survivors are encouraged and invited to attend, caregivers and medical professionals wanting to learn more about lung cancer survivorship are also welcome to register to attend. All conference sessions will be geared toward those who have been diagnosed with lung cancer.
LOCATION
Moffitt Cancer Center
Vincent A. Stabile Research Building, Ted and Marty Couch Auditorium
12902 Magnolia Drive
Tampa, FL 33612
REGISTER NOW
OR
Attend by webinar! Register to attend online via Zoom.
ABOUT THIS EVENT
On Saturday, March 7, in Tampa, Florida, LUNGevity is partnering with Patient Power for HOPE Summit Live! — a free in-person forum at Moffitt Cancer Center, where you and your loved one can hear the latest in treatment and research from leading lung cancer experts. Hear about emerging therapies, understand current treatment options, and learn about support resources.
During this interactive summit, you will have the opportunity to meet and to connect with experts, other patients, survivors, and caregivers touched by lung cancer. Our hope is that you’ll share your knowledge with your peers, learn, and become inspired!
Please join us in person for this FREE interactive summit to learn:
Explaining lung cancer today
What do we know and what do we do about it?
Where are we headed and how quickly?
How is this personalized to you? What does this mean to you?
Patient, caregiver, nurse, and social worker perspective: how to live well
Tips and resources
How and when to get support
Financial, social, and logistical information
Our expert panel will take your submitted questions, and advocates will be on hand to offer support and to connect with a broad range of resources.
Guest Presenters
David Carbone, MD, PhD
Director, James Thoracic Center, James Cancer Hospital and Solove Research Institute
Scott J. Antonia, MD, PhD
Program Leader, Thoracic Oncolocy, Moffitt Cancer Center
Sponsors
This in-person forum is sponsored by the Patient Empowerment Network through educational grants from Pfizer, Genentech, and Novartis, with additional funding from LUNGevity.
http://lungevity.donordrive.com/index.cfm?fuseaction=donorDrive.event&eventID=532
-----------------------------------------------------------
Now digging deeper:
1) Check out the Scientific Advisory Board of LUNGevity and notice David Carbone is here and remember, David Carbone out of all these global leaders... was chosen to lead, as President.. IASLC
http://lungevity.org/about-us/our-people/scientific-advisory-board
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=106237896
https://www.iaslc.org/about-us/board
2) Lots of names on the survivor stories... if any connect to other dots then I'll report back but Peregrine followers are building quick and naturally, any survivors/family members will be the first to start following the company that gives hope to family/friends/relatives..etc
http://lungevity.org/support-survivorship/survivor-resource-center/survivor-stories
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM